ERCC1 expression in circulating tumor cells (CTCs) using a novel detection platform correlates with progression-free survival (PFS) in patients with metastatic non-small-cell lung cancer (NSCLC) receiving platinum chemotherapy

Millie Das, Richard H. Bruce, Paul Frankel et al.|Lung Cancer|2012

Cited by 59